Several such interventions targeting the gut microbiota milieu through strategic dietary manipulations, probiotic formulations and prebiotic supplements hold considerable promise in promoting health and amelioration of diverse disease conditions
June 10, 2025: Taking Ozempic Doubles a Persons Risk of a Type of Vision Loss The European Medicines Agency (EMA) has concluded that taking Ozempic doubles a persons risk of developing a type of vision loss called nonarteritic anterior ischemic optic neuropathy or NAION
Kitzman DW, Brubaker P, Morgan T et al (2016) Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial
Supporting Research and Development: The Role of Biocytogen To facilitate the development of these next-generation therapies, Biocytogen offers a comprehensive portfolio of obesity-related mouse models
Angelia struggled with menopausal weight gain for nearly nine years
The newer generation tells a more compelling story